Thrivent Financial for Lutherans
HUMA icon

Thrivent Financial for Lutherans’s Humacyte HUMA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-237,431
Closed -$496K – 2493
2025
Q2 		$496K Buy
+237,431
New +$456K ﹤0.01% 2147
2025
Q1 		– Sell
-415,262
Closed -$2.1M – 2445
2024
Q4 		$2.1M Buy
415,262
+284,368
+217% +$1.41M ﹤0.01% 1399
2024
Q3 		$712K Buy
+130,894
New +$863K ﹤0.01% 2091

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Thrivent Financial for Lutherans's HUMA Position: Q3 2025 in Review

Thrivent Financial for Lutherans sold out of Humacyte (HUMA) in Q3 2025, closing a stake of 237,431 shares — an estimated $496K sold.

Thrivent Financial for Lutherans first reported a position in HUMA in Q3 2024 and held it in 3 quarters. The position peaked at $2.1M in Q4 2024. 141 funds tracked by Wall St. Rank hold HUMA as of Q3 2025.

  • Thrivent Financial for Lutherans reported no remaining Humacyte position as of Q3 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 237,431 Humacyte shares in Q3 2025, an estimated $496K.
  • Thrivent Financial for Lutherans first reported a position in Humacyte in Q3 2024 and held it in 3 quarters.
  • Thrivent Financial for Lutherans's Humacyte position peaked at $2.1M in Q4 2024.
  • 141 funds tracked by Wall St. Rank held Humacyte as of Q3 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2025, filed 4 Nov 2025.